Quick Answer
Clearside Biomedical, Inc. reported Stockholders Equity of -$38.85 million for fiscal year 2024.
Clearside Biomedical, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$38.85M | -144.2% |
| 2023 | -$15.91M | -250.0% |
| 2022 | $10.61M | -72.1% |
| 2021 | $37.98M | +333.4% |
| 2020 | $8.76M | -21.5% |
| 2019 | $11.16M | -52.8% |
| 2018 | $23.62M | +10.3% |
| 2017 | $21.41M | -70.1% |
| 2016 | $71.66M | +295.5% |
| 2015 | -$36.66M | -90.8% |
| 2014 | -$19.21M | -78.9% |
| 2013 | -$10.74M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$53.95M | -55.1% | -10.7% |
| June 30, 2025 | -$48.73M | -72.3% | -6.2% |
| March 31, 2025 | -$45.91M | -110.5% | -18.2% |
| December 31, 2024 | -$38.85M | -144.2% | -11.7% |
| September 30, 2024 | -$34.79M | -170.8% | -23.0% |
| June 30, 2024 | -$28.29M | -468.8% | -29.7% |
| March 31, 2024 | -$21.81M | -907.8% | -37.1% |
| December 31, 2023 | -$15.91M | -250.0% | -23.8% |
- Clearside Biomedical, Inc. showed a decrease of -144.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2013–2024 period, Clearside Biomedical, Inc.’s stockholders equity has declined by 261.9% (from -$10.74 million to -$38.85 million).
- The most recent figure is from Clearside Biomedical, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: